Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues        
Total revenues $ 42,750 $ 47,086 $ 137,352 $ 148,466
Cost of sales        
Total cost of sales 40,826 47,395 130,703 141,706
Gross profit (loss) 1,924 (309) 6,649 6,760
Operating expenses        
Research and development 20,455 22,382 64,822 78,357
Sales and marketing 8,549 16,204 28,596 56,299
General and administrative 9,528 18,924 50,673 62,472
Impairment charges 6,062   6,062  
Goodwill impairment 2,450 0 2,450 229,500
Total operating expenses 47,044 57,510 152,603 426,628
Loss from operations (45,120) (57,819) (145,954) (419,868)
Interest expense (1,045) (680) (2,965) (1,281)
Interest and other expense, net (349) (1,677) (498) (8,443)
Loss before income taxes (46,514) (60,176) (149,417) (429,592)
Income tax benefit (expense) 141 (598) 675 1,602
Net loss $ (46,373) $ (60,774) $ (148,742) $ (427,990)
Net loss per share-Basic $ (0.14) $ (0.19) $ (0.46) $ (1.36)
Net loss per share-Diluted $ (0.14) $ (0.19) $ (0.46) $ (1.36)
Weighted average shares outstanding, basic 323,187,608 316,007,716 321,328,016 313,901,704
Weighted average shares outstanding, diluted 323,187,608 316,007,716 321,328,016 313,901,704
Products        
Revenues        
Total revenues $ 37,502 $ 42,937 $ 121,597 $ 135,085
Cost of sales        
Total cost of sales 37,175 43,639 119,290 130,454
Services        
Revenues        
Total revenues 5,248 4,149 15,755 13,381
Cost of sales        
Total cost of sales $ 3,651 $ 3,756 $ 11,413 $ 11,252